Literature DB >> 1281238

Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells.

J Crown, C Wassherheit, T Hakes, D Fennelly, L Reich, M Moore, J Schneider, J Curtin, S C Rubin, B Reichman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1281238     DOI： 10.1093/jnci/84.24.1935

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Optimal versus maximally tolerated dose in cancer chemotherapy treatment.

Authors:  M Markman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  High-dose chemotherapy of metastatic breast cancer: the end of the beginning?

Authors:  J Crown
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 3.  Current concepts of treatment in medical oncology: new anticancer drugs.

Authors:  C Unger
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

4.  Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factor.

Authors:  S Leyvraz; N Ketterer; L Perey; J Bauer; P Vuichard; J P Grob; P Schneider; V von Fliedner; F Lejeune; F Bachmann
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.